TIRZEPATIDE 10MG

Tirzepatide is an advanced dual-agonist peptide designed to engage the GLP-1 and GIP receptor pathways simultaneously. This complementary incretin mechanism gives researchers a powerful tool for exploring glucose regulation, insulin signalling, appetite pathways, lipid metabolism and body-composition models.

By combining two metabolic receptor systems within a single molecule, Tirzepatide offers a broader research profile than single-pathway GLP-1 compounds. Its extended signalling characteristics make it especially valuable for comparative studies involving metabolic adaptation, energy balance and endocrine regulation.

Choice Peptides Tirzepatide 10 mg is supplied as a high-purity lyophilized powder and meticulously tested for identity, purity and consistency.

Form: Lyophilized peptide powder
Contents: 10 mg per vial
Purity: ≥99%
Testing: Meticulously tested for identity, purity and consistency
Storage: Keep in a cool, dry environment; refrigerate at 2°C–8°C after reconstitution
Intended use: For laboratory research purposes only. Not for human or veterinary use.